ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Bupivacaine

Also written as “HTX-011”, “SKY0402” and “Bupivacaine HCl”.

Its studies are mostly in Pain, Postoperative · Pain · Hernia, Inguinal · Bunion · Hemorrhoids, led by 10 companies.

Drug pageBupivacaine: every studyMany companies study it; this page follows only the 56 they lead. All 1,200 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Oct 24, 201156 company-led studies, 4 open or runningNext primary completion: Nov 2026 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Pacira BioSciences230 open or runningphase 4since Oct 24, 2011Jun 11, 2007none ahead
Heron Therapeuticsits history only171 open or runningphase 4since Oct 10, 2018Jun 9, 2015none ahead
Innocollits history only60 open or runningphase 3since Aug 12, 2015Oct 18, 2010none ahead
Bausch Health Companiesits history only20 open or runningphase 3since Oct 9, 2015Mar 30, 2010none ahead
Cristália Produtos Químicos Farmacêuticos Ltda.its history only20 open or runningphase 3since Feb 23, 2011Feb 23, 2011none ahead
Jiangsu HengRui Medicineits history only22 open or runningphase 4since Mar 13, 2024Mar 13, 2024Nov 2026phase 2 · NCT06529432
Ascension Healthits history only10 open or runningphase 3since Nov 20, 2019Nov 20, 2019none ahead
Liquidia Technologiesits history only10 open or runningphase 1since Nov 22, 2016Nov 22, 2016none ahead
Rebel Medicineits history only11 open or runningphase 2since Apr 28, 2026Apr 28, 2026none ahead
Tian Medicalits history only10 open or runningphase 4since Oct 16, 2012Oct 16, 2012none ahead

Also a collaborator on its studies: Pfizer, Premier Research Group and Richmond Pharmacology.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Pacira BioSciences only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 4 studies since Jun 11, 2007.

  1. Aug 28, 20082 phase 3 studiesNCT00744848, NCT00745290
  2. Dec 9, 2008Phase 3 study in PainNCT00813111 · 136 enrolled · United States
  3. Dec 9, 20082 phase 1 studiesNCT00812305, NCT00806806
  4. Dec 9, 2008Phase 2 study in Pain, PostoperativeNCT00807209 · 3 enrolled · United States
  5. Apr 28, 20092 phase 3 studiesNCT00890721, NCT00890682
  6. Sep 15, 20103 phase 2 studiesNCT01203644, NCT01206608, NCT01206595
  7. Oct 24, 2011Phase 4 study in Intestinal ObstructionNCT01507220 · 2 enrolled · United States
  8. May 16, 2014Phase 4 study in ObesityNCT02142829 · 101 enrolled · United States
  9. Sep 23, 2014Phase 4 study in PainNCT02255500 · 23 enrolled · United States
  10. Nov 3, 2014Phase 4 study in PainNCT02284386 · 15 enrolled · United States
  11. Jul 19, 2015Phase 3 study in ToothacheNCT02517905 · 166 enrolled · United States
  12. Mar 15, 2016Phase 4 study in PainNCT02713490 · 140 enrolled · United States
  13. Jun 25, 2019Phase 1 study in BunionNCT04002089 · 45 enrolled · United States
  14. Aug 4, 2020Phase 3 study in BunionNCT04518462 · 121 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 23 Pacira BioSciences leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT04518462Bunion · United States3CompletedApr 5, 2021121
NCT04002089Bunion · United States1CompletedDec 2, 201945
NCT02713490Pain · United States4CompletedFeb 8, 2017140
NCT02517905Toothache · United States3CompletedJan 2016166
NCT02284386Pain · United States4CompletedMar 201515
NCT02255500Pain · United States4CompletedMar 201523
NCT02142829Obesity · United States4CompletedMar 2013101
NCT01507220Intestinal Obstruction · United States4TerminatedJul 20122
NCT01206608Pain, Postoperative · United States2CompletedAug 200840
NCT01206595Pain, Postoperative2CompletedMar 200658
NCT01203644Hernia, Inguinal2CompletedJan 200676
NCT00890721Hemorrhoids · Poland3CompletedNov 2009189
NCT00890682Bunion · United States3CompletedNov 2009193
NCT00813111Pain · United States3TerminatedFeb 2009136
NCT00812305Pain · Poland1CompletedAug 200916
NCT00807209Pain, Postoperative · United States2TerminatedFeb 20093
NCT00806806Agnosia · United States1CompletedFeb 2009128
NCT00745290Pain, Postoperative · United States3CompletedJan 2009245
NCT00744848Hemorrhoids · United States3CompletedFeb 2009204
NCT00529126Pain, Postoperative · United States, Georgia2CompletedDec 2007100
NCT00485693Pain, Postoperative · United States, Czechia2CompletedAug 2009138
NCT00485667Pain, Postoperative · United Kingdom1CompletedAug 200748
NCT00485433Pain, Postoperative · United States2CompletedDec 200798

How it is read

Names in the registry

  • “HTX-011”, 20 entries
  • “SKY0402”, 12 entries
  • “Bupivacaine HCl”, 7 entries
  • “Bupivacaine”, 5 entries
  • “Bupivacaine Liposome Injection”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.